|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/54 | |
| C12N 9/94 |
| (11) | Patento numeris | 3003360 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14859866.7 |
| Europos patento paraiškos padavimo data | 2014-11-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/063984 |
| Data | 2014-11-05 |
| (87) | Numeris | WO 2015/069677 |
| Data | 2015-05-14 |
| (30) | Numeris | Data | Šalis |
| 201361900092 P | 2013-11-05 | US |
| (72) |
PERRETT, Stephen, US
BECKER, Robert, DE
BOLTRI, Luigi, IT
GHIDORSI, Luigi, IT
ARZUFFI, Paola, IT
PIRONTI, Vincenza, IT
|
| (73) |
Allergan Pharmaceuticals International Limited,
Clonshaugh Business & Technology Park, Dublin 17, D17 E400,
IE
|
| (54) | HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS |
| HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS |